Date of Birth    April 5, 1963

• 1987 Joined the Company
• 2008 Department Manager of Lifecycle Management Dept. II
• 2009 Department Manager and Lifecycle Leader of Lifecycle Management Dept. II
• 2011 President of Roche Products (Ireland) Limited
• 2013 Head of Oncology Unit, Marketing & Sales Div. of the Company
• 2014 Executive Officer, Head of Oncology Unit,
  Marketing & Sales Div. of the Company
• 2015 Executive Officer, Head of Corporate Planning Dept. of the Company
• 2017 Executive Vice President, Head of Corporate Planning Dept. of the Company
• 2018 Executive Vice President, Co-Head of Project & Lifecycle Management Unit
• 2020 Representative Director and President (to present)
  COO
• 2021 CEO (to present)

Date of Birth    July 12, 1957

• 1991 Joined Nippon Roche K.K.
• 2002 Department Manager of Pharmaceutical Research Dept. IV
• 2007 Director, Forerunner Pharma Research Co., Ltd.
• 2009 Vice President and General Manager of Research Div.
  Head, C&C Research Laboratories (Korea)
• 2012 Director and COO, Chugai Pharmabody Research Pte. Ltd. (Singapore)
• 2016 Senior Vice President and General Manager of Research Div.
• 2018 Executive Vice President and Head of Translational Research Div.
• 2018 Executive Vice President (to present)
• 2022 Director (to present)

Date of Birth    November 23, 1960.

• 1983 Joined the Company
• 2007 General Manager of Finance & Accounting Dept.
• 2010 Department Manager of Planning & Research Dept.
• 2012 Department Manager of Marketing & Sales Planning Dept.
• 2015 Vice President, General Manager of Finance & Accounting Dept.
• 2018 Executive Vice President & CFO (to present)
  Head of Finance Supervisory Div.
  Head of IT Supervisory Div. and Head of Finance & Accounting Dept.
• 2022 Director (to present)

Date of Birth    February 24, 1948

• 1994 Head of Department of Pediatrics, Jichi Medical University
• 2006 Director of Jichi Children’s Medical Center Tochigi
• 2010 Dean of School of Medicine, Jichi Medical University
• 2012 Visiting Professor of School of Medicine, Shinshu University (to present)
• 2013 Professor Emeritus of Jichi Medical University (to present)
  Vice President of International University of Health and Welfare
• 2014 Director of Japanese Medical Specialty Board (part-time)
• 2015 Vice President of International University of Health and Welfare and Head of IUHW Hospital
• 2017 Chief Medical Officer of Ryoumou Seishi Ryogoen, Kiryu Ryoiku Futabakai Social Welfare Corporation
• 2018 Regent of Tokyo Medical University (part-time) (to present)
• 2020 Director of the Company (to present)

Date of Birth    July 6, 1949

• 1975 Joined Tateisi Electronics Co. (currently OMRON Corporation)
• 1997 Director of OMRON Corporation (“OMRON”)
• 1999 Managing Executive Officer of OMRON
• 2001 Senior General Manager, Corporate Strategic Planning HQ of OMRON
• 2003 Executive Officer and Executive Vice President of OMRON
  President, Industrial Automation Business Company of OMRON
• 2008 Director and Executive Vice Chairman of OMRON
• 2013 Chairman of the Board of OMRON
• 2023 Director of the Company (to present)
  Honorary advisor of OMRON Corporation

Date of Birth    May 20,1960

• 1983 Joined The Dai-ichi Mutual Life Insurance Company
• 2012 Director, Managing Executive Officer, Deputy Chief General Manager of Group Management Headquarters, and General Manager of Corporate Planning Department of The Dai-ichi Life Insurance Company, Limited. (“DLI”)
• 2013 Director, Managing Executive Officer, and Deputy Chief General Manager of Group Management Headquarters of DLI
• 2015 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of DLI
• 2016 Director, Senior Managing Executive Officer, and General Manager of Marketing Promotion of Dai-ichi Life Holdings, Inc. (“DLH”)
  Director and Senior Managing Executive Officer of DLI
• 2017 Director of DLH
  Representative Director and Vice Chairman of DLI
• 2020 Director, Vice Chairman, and General Manager of Innovation Strategy Unit of DLH
• 2021 Representative Director, Vice Chairman, and Executive Officer of DLH
• 2022 Director of DLH
  President of Dai-ichi Life Research Institute, Inc. (to present)
• 2023 Director of the Company (to present)
  Outside Director of Imperial Hotel, Ltd. (to present)

Date of Birth    May 2, 1960

• 1990 Joined Deutsche Lufthansa AG
• 1994 Member of the Executive Board and CEO of Passenger Transport Division of Deutsche Bahn AG
• 2004 CEO of Swiss International Air Lines AG
• 2009 Deputy Chairman of the Executive Board of Deutsche Lufthansa AG
• 2011 Chairman of the Executive Board and CEO of Deutsche Lufthansa AG
• 2014 Chairman of the Board of Directors of Roche Holding Ltd.
• 2017 Director of the Company (to present)

Date of Birth    December 19, 1958

• 1997 Co-founder, President and CEO of Cytokinetics
• 2008 President and CEO of Arete Therapeutics
• 2010 Global Head and Vice President of Genentech Partnering
• 2013 Global Head and Senior Vice President of Genentech Partnering
• 2018 Global Head of Roche Pharma Partnering and Member of the Roche Enlarged Corporate Executive Committee (to present)
• 2019 Director of the Company (to present)

Date of Birth    December 30, 1973

• 2005 Joined Genentech, Inc. as Product Manager
• 2010 Sales Manager of Genentech
• 2011 Marketing Director, Rituxan Immunology of Genentech
• 2012 Marketing Director, ACTEMRA of Genentech
• 2013 Senior Director, Field Reimbursement Management of Genentech
• 2015 Lifecycle Leader, ACTEMRA of Roche
• 2017 Vice President, Rheumatology / Nephrology of Genentech
• 2018 Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lung & GI Oncology Sales of Genentech
• 2019 Head, Global Product Strategy of Roche Pharmaceuticals
• 2023 CEO of Roche Pharma, F. Hoffmann-La Roche Ltd.
  Director of the Company (to present)

Date of Birth    January 8, 1960

• 1988 Joined the Company
• 2004 Department Manager, Quality & Regulatory Compliance Dept.
• 2009 Department Manager, Drug Safety Coordination Dept.
• 2011 Global PV Head, Pharmacovigilance Manager
• 2013 Head of Drug Safety Div. and Department Manager of Drug Safety Coordination Dept.
• 2015 Vice President, Head of Drug Safety Div.
  Vice President, Head of Quality & Regulatory Compliance Unit, and Head of Drug Safety Div.
• 2018 Senior Vice President, Head of Quality & Regulatory Compliance Unit and Head of Drug Safety Div.
• 2021 Senior Vice President
  Audit & Supervisory Board Member (to present)

Date of Birth    August 5, 1964

• 2005 Joined the Company
• 2016 Department Manager of PT Planning Dept.
• 2018 Department Manager of Corporate Planning Dept. of Chugai Pharma Manufacturing Co., Ltd.
• 2019 Head of Corporate Social Responsibility Dept.
  Head of Sustainability Dept.
• 2023 Executive Director of Human Resources Management Dept.
  Audit & Supervisory Board Member (to present)

Date of Birth    October 25, 1949

• 1974 Joined Arthur Young & Co., Tokyo Office
• 1980 Seconded to Asahi & Co., Osaka Office
• 1983 Seconded to Arthur Young & Co., Los Angeles Office
• 1989 Partner, Asahi Shinwa & Co.
• 1993 Joined Showa Ota & Co.
• 1997 Senior Partner, Showa Ota & Co.
• 2008 Executive Board Member, Ernst & Young ShinNihon LLC
• 2010 Established Nimura Certified Public Accountant Office
• 2012 Outside Director, Sony Corporation
• 2016 Outside Audit & Supervisory Board Member of the Company (to present)

Date of Birth    January 11, 1963

• 1988 Registered as an attorney-at-law (Daini Tokyo Bar Association)
  Joined Anderson Mōri & Tomotsune
• 1993 Registered as an attorney-at-law in the state of New York
• 1997 Partner of Anderson Mōri & Tomotsune (to present)
• 2007 Outside Corporate Auditor of LIFENET INSURANCE COMPANY
• 2010 Part-time Lecturer at School of Law, The University of Tokyo
• 2011 Outside Corporate Auditor of Bridgestone Corporation
• 2016 Outside Director of Bridgestone Corporation (to present)
  Outside Audit & Supervisory Board Member of Mercuria Holdings Co., Ltd. (formerly Mercuria Investment Co., Ltd.) (to present)
• 2019 Visiting Professor of School of Law, The University of Tokyo
• 2020 Outside Audit & Supervisory Board Member of the Company (to present)

Date of Birth    January 29, 1960

• 1985 Joined Matsuda Masayuki Law & Patent Office (currently Mori Hamada & Matsumoto)
• 2004 Vice President of Daini Tokyo Bar Association
• 2005 Executive Governor of Japan Federation of Bar Associations
• 2013 Joined Tokyo Roppongi Law & Patent Office
• 2014 Outside Audit & Supervisory Board Member of Kao Corporation
• 2015 Outside Audit & Supervisory Board Member of Asahi Group Holdings, Ltd.
• 2016 President of Daini Tokyo Bar Association
  Vice President of Japan Federation of Bar Associations
• 2021 Outside Audit & Supervisory Board Member of IHI Corporation (to present)
• 2023 Outside Audit & Supervisory Board Member of the Company (to present)